1 vs 7 RATG Infusions in Renal Transplantation

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

July 30, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Kidney Replacement

Interventions

DRUG

RATG

Thymoglobulin, Genzyme corporation, Italy.

DRUG

Basiliximab

Simulect, Novartis, Italy.

Trial Locations (1)

ASST HPG23 - Unità di Nefrologia, Bergamo

All Listed Sponsors

lead

Mario Negri Institute for Pharmacological Research

OTHER